Flyer

Translational Biomedicine

  • ISSN: 2172-0479
  • Journal h-index: 18
  • Journal CiteScore: 5.91
  • Journal Impact Factor: 4.11
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Disease concepts and molecular medicine: the ethical significance of conceptually examining new biomedical technologies

John Armin*

When anticipating ethical issues associated with biomedical technologies, this article argues that it is helpful to begin with an examination of implied disease concepts. Additionally, it demonstrates that this can be accomplished at an early stage. When a technology is still in its infancy molecular medicine is the specific case that is being examined here. A "cascade model" of disease processes and a personal pattern" model of bodily function are combined in this group of new technologies. While the first's ethical implications are somewhat reminiscent of earlier, albeit contentious, preventive and predictive medicine methods, the seconds are quite novel and could have far-reaching implications.

Keywords

Concept of disease; Ethics; Emerging technology; Epistemology; Molecular medicine; personalized medicine; Health technology assessment

Published Date: 2023-01-31; Received Date: 2023-01-03